These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 5843824)
1. Ergotism due to therapeutic doses of ergotamine tartrate. Enge I; Sivertssen E Am Heart J; 1965 Nov; 70(5):665-70. PubMed ID: 5843824 [No Abstract] [Full Text] [Related]
2. [A minor case of ergotism appearing to be connected with a potentialisation of ergotamine tartrate by erythromycine ethyl-succinate (author's transl)]. Lagier G; Castot A; Riboulet G; Boesh C Therapie; 1979; 34(4):515-21. PubMed ID: 531783 [No Abstract] [Full Text] [Related]
3. [Risks related to the use of ergotamine in the therapy of hemicrania. Description of a case]. Bocchia M; Baldini GG; Bertola G; Zorzoli C Recenti Prog Med; 1991; 82(7-8):390-3. PubMed ID: 1947404 [TBL] [Abstract][Full Text] [Related]
4. Arteriospasm after ergotamine tartrate in infectious hepatitis. Katz AI; Massry SG; Tikva P Arch Intern Med; 1966 Jul; 118(1):62-4. PubMed ID: 5940196 [No Abstract] [Full Text] [Related]
5. [Acute ergotism with a therapeutic association josamycin/ergotamine (author's transl)]. Grolleau JY; Martin M; de la Guerrande BD; Barrier J; Peltier P Therapie; 1981; 36(3):319-21. PubMed ID: 7292409 [No Abstract] [Full Text] [Related]
6. [Ergotism as the cause of typical peripheral blood circulation disorders. Observations on an ergotamine addicted woman]. Bodner E; Flora G Med Klin; 1967 Feb; 62(7):254-6. PubMed ID: 5595329 [No Abstract] [Full Text] [Related]